Lack of injectable anti-HIV therapies in the Japanese market limits treatment options for dysphagic patients

hiv
This is not the first time that the Japan HAART market has lagged behind other countries with sizeable HIV-infected populations. Credit: PENpics Studio/Shutterstock.